The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 1, 2012, Pages 44-48

  Guzzo, Thomas J ^a   McNeil, Brian K ^a   Bivalacqua, Trinity J ^a   Elliott, Debra J ^a   Sokoll, Lori J ^a   Schoenberg, Mark P ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bladder cancer; Circulating tumor cells; Staging

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CYSTECTOMY; FEMALE; HUMAN; HYDRONEPHROSIS; MALE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84855642295     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.10.008     Document Type: Article

References (14)

1. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy. Eur Urol 2007, 51:137-149.
2. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
3. Raj G.V., Bochner B.H. Radical cystectomy and lymphadenectomy for invasive bladder cancer: Towards evolution of an optimal surgical standard. Semin Oncol 2007, 34:110-121.
4. Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 1869, 14:146-149.
5. Ross J.S., Slodkowska E.A. Circulating and disseminated tumor cells in the management of breast cancer. Am J Clin Pathol 2009, 132:237-245.
6. Sastre J., Maestro M.L., Puente J., et al. Circulating tumor cells in colorectal cancer: Correlation with clinical and pathologic variables. Ann Oncol 2008, 19:935-938.
7. Okegawa T., Nutahara K., Higashihara E. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol 2009, 181:1091-1097.
8. Naoe M., Ogawa Y., Morita J., et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch system. Cancer 2007, 109:1439-1445.
9. Balic M., Dandachi N., Hofmann G., et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 2005, 68:25-30.
10. Gallagher D.J., Milowsky M.I., Ishill N., et al. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 2009, 20:305-308.
11. Allard W.J., Matera J., Miller M.C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not healthy subject or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
12. Cohen S.J., Punt C.J., Iannotti N., et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009, 20:1223-1229.
13. Pierga J.Y., Bidard F.C., Mathiot C., et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 2008, 14:7004-7010.
14. Budd G.T., Cristofanilli M., Ellis M.J., et al. Circulating tumor cells versus imaging: Predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006, 12:6403-6409.